Voloridge Investment Management, LLC Reata Pharmaceuticals Inc Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $12 Million - $16 Million	151,542 Added 94.82%	311,358 $31.7 Million
Q1 2023 May 15, 2023	SELL	$30.85 - $93.17 $1.79 Million - $5.41 Million	-58,031 Reduced 26.64%	159,816 $14.5 Million
Q4 2022 Feb 14, 2023	SELL	$22.15 - $42.11 $2.26 Million - $4.29 Million	-101,933 Reduced 31.88%	217,847 $8.28 Million
Q3 2022 Nov 14, 2022	BUY	$19.41 - $36.49 $1.96 Million - $3.68 Million	100,927 Added 46.12%	319,780 $8.04 Million
Q2 2022 Aug 15, 2022	SELL	$20.71 - $36.5 $734,210 - $1.29 Million	-35,452 Reduced 13.94%	218,853 $6.65 Million
Q1 2022 May 16, 2022	SELL	$24.12 - $39.6 $1.65 Million - $2.7 Million	-68,281 Reduced 21.17%	254,305 $8.33 Million
Q4 2021 Feb 14, 2022	BUY	$25.61 - $110.96 $8.26 Million - $35.8 Million	322,586 New	322,586 $8.51 Million
Q3 2021 Nov 15, 2021	SELL	$100.0 - $143.02 $7.1 Million - $10.2 Million	-70,990 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$78.27 - $151.29 $4.25 Million - $8.22 Million	54,301 Added 325.37%	70,990 $10 Million
Q1 2021 May 17, 2021	BUY	$94.25 - $132.81 $1.57 Million - $2.22 Million	16,689 New	16,689 $1.66 Million
Q2 2020 Aug 14, 2020	SELL	$126.3 - $176.56 $363,744 - $508,492	-2,880 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$124.16 - $247.74 $1.45 Million - $2.89 Million	-11,652 Reduced 80.18%	2,880 $416,000
Q4 2019 Feb 14, 2020	BUY	$74.57 - $217.92 $1.08 Million - $3.17 Million	14,532 New	14,532 $2.97 Million
Q2 2019 Aug 14, 2019	SELL	$77.72 - $94.35 $409,739 - $497,413	-5,272 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$51.9 - $101.79 $273,616 - $536,636	5,272 New	5,272 $451,000

Others Institutions Holding RETA

# of Institutions

Shares Held

62.7K

Call Options Held

Put Options Held

View Full List

About REATA PHARMACEUTICALS INC

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

More about RETA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account